Author

Christer Paul

Observed names: C Paul, C Y Paul, C. Paul, Christer Y. Paul

Institutions: Karolinska University Hospital, Karolinska Institutet

Observed institutions: Novartis (Switzerland), Karolinska University Hospital, Uppsala University Hospital, Örebro University, Sahlgrenska University Hospital, Danderyds sjukhus, Karolinska Institutet, Stockholm South General Hospital, Integrated Cardio Metabolic Centre, Örebro University Hospital, Skåne University Hospital, Linköping University Hospital

OpenAlex ID: A5037248931

Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

2012 · Sören Lehmann, Vladimir J.N. Bykov, et al. · Journal of Clinical Oncology · 406

PDF

Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy.

1990 · S Vitols, B Angelin, et al. · Proceedings of the National Academy of Sciences · 132

Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia

2010 · S Deneberg, M Grövdal, et al. · Leukemia · 120

BCRP mRNA expression v. clinical outcome in 40 adult AML patients

2004 · Bertil Uggla, Elisabet Ståhl, et al. · Leukemia Research · 102

P-Glycoprotein Inhibitor Valspodar (PSC 833) Increases the Intracellular Concentrations of Daunorubicin In Vivo in Patients With P-Glycoprotein–Positive Acute Myeloid Leukemia

2000 · U. Tidefelt, J. Liliemark, et al. · Journal of Clinical Oncology · 101

Expression of glutathione transferase pi as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia.

1992 · U Tidefelt, A Elmhorn-Rosenborg, et al. · PubMed · 96

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks

2011 · Stefan Deneberg, Philippe Guardiola, et al. · Blood · 81

Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity

2002 · Linda Björkhem-Bergman, Kerstin Jönsson, et al. · Biochemical Pharmacology · 77

APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells

2010 · Dina Ali, Kerstin Jönsson-Videsäter, et al. · European Journal Of Haematology · 70

PRIMA‐1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion

2005 · H. Nahi, M. Merup, et al. · British Journal of Haematology · 62

PDF

Effects of PRIMA‐1 on chronic lymphocytic leukaemia cells with and without hemizygous p53 deletion

2004 · H. Nahi, S. Lehmann, et al. · British Journal of Haematology · 60

PDF

Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system

2003 · Kerstin Jönsson-Videsäter, Linda Björkhem-Bergman, et al. · Biochemical Pharmacology · 60

High‐dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia

2002 · Helene Hallböök, Bengt Simonsson, et al. · British Journal of Haematology · 57

Mutated and non‐mutated TP53 as targets in the treatment of leukaemia

2008 · H. Nahi, G. Selivanova, et al. · British Journal of Haematology · 56

Increased remissions from one course for intermediate‐dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population‐based phase II study

2003 · Gunnar Juliusson, Martin Höglund, et al. · British Journal of Haematology · 54

A retrospective analysis of bleeding complications in 438 patients with acute leukaemia during the years 1972–1991

1993 · E. Törnebohm, D. Lockner, et al. · European Journal Of Haematology · 53

A Comparative Randomized Trial of Low-Dose Versus High-Dose Streptokinase in Deep Vein Thrombosis of the Thigh

1984 · Sam Schulman, Dieter Lockner, et al. · Thrombosis and Haemostasis · 53

Cardiac systolic function before and after hematopoietic stem cell transplantation

2000 · S Lehmann, B Isberg, et al. · Bone Marrow Transplantation · 52

Pharmacokinetics of Daunorubicin and Doxorubicin in Plasma and Leukemic Cells from Patients with Acute Nonlymphoblastic Leukemia

1989 · Christer Paul, Jan Liliemark, et al. · Therapeutic Drug Monitoring · 50

Anti‐leukaemic effects induced by APR‐246 are dependent on induction of oxidative stress and the NFE2L2/HMOX1 axis that can be targeted by PI3K and mTOR inhibitors in acute myeloid leukaemia cells

2016 · Dina Ali, Dara K. Mohammad, et al. · British Journal of Haematology · 49

Selenite is a potent cytotoxic agent for human primary AML cells

2009 · Eric Olm, Kerstin Jönsson-Videsäter, et al. · Cancer Letters · 49

Fibrinopeptide a (FPA) in patients with acute myocardial infarction

1979 · Hans Johnsson, Erik Orinius, et al. · Thrombosis Research · 49

Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype

2010 · H Gréen, I J Falk, et al. · The Pharmacogenomics Journal · 48

Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia

1980 · Christer Paul, Roger Baurain, et al. · Cancer Letters · 43

Alteration of pharmacokinetics of cyclophosphamide and suppression of the cytochrome P450 genes by ciprofloxacin

2003 · H-J Xie, L Griskevicius, et al. · Bone Marrow Transplantation · 42

Works count: 120

Citation count: 3,174

H-index: 33

I10-index: 71